Ping Lee, PhD
University of Toronto
Dr. Ping I. Lee is Professor in Pharmaceutical Sciences at the Leslie Dan Faculty of Pharmacy, University of Toronto, who also served as the inaugural GlaxoSmithKline Chair from 2004 to 2014. He received his B.Sc. in Chemical Engineering from National Taiwan University and his Ph.D. in Physical Chemistry from Michigan State University. He began his career in the industry and held senior research and management positions in drug delivery and pharmaceutical R&D at several major pharmaceutical companies in the US for a total of 25 years: Ciba-Geigy, SmithKline and Schering-Plough. In between, he also served as a tenured full professor in the Faculty of Pharmacy, University of Toronto from 1988 to 1993. Prior to returning to Toronto in July 2004 for the GlaxoSmithKline Chair, he was Senior Director of Pharmaceutical R&D at Schering-Plough Research Institute in Kenilworth, NJ.
Dr. Lee's research interests and publications cover topics in enhanced delivery of poorly soluble drugs, evolution of supersaturation generation of amorphous pharmaceuticals, controlled release nitric oxide for diabetic wound healing, modified-release dosage forms, hydrogels and polymeric drug delivery systems, swellable and erodible matrix systems, kinetics and mechanisms of drug release, and diffusion and mass transfer in polymers. He has 95 scientific publications and 45 patents/patent applications including 23 issued patents. He was an inaugural Editorial Board member of both the Journal of Controlled Release (1983-1997) and European Journal of Pharmaceutical Sciences (1992-1998). He also served on the Board of Governors of the Controlled Release Society (1986-1989) and was a founding Chair of the AAPS Modified Release Focus Group (2002-2004). He currently serves on the Editorial Boards of Molecular Pharmaceutics, Biopharmaceutics & Drug Disposition, Pharmaceutical Development and Technology, Acta Pharmaceutica Sinica B, and Pharmaceutical Fronts. He is a Fellow of AAAS (American Association for the Advancement of Science; elected 1996) and AAPS (American Association of Pharmaceutical Scientists; elected 2013). More recently, he was the recipient of the AFPC (Association of Faculties of Pharmacy of Canada)/Pfizer Research Career Award (2019).